Mukka Proteins Hits New 52-Week Low at Rs. 24.5 Amid Decline

Mukka Proteins, a microcap player in the FMCG sector, has reached a significant milestone by hitting a new 52-week low of Rs. 24.5 on October 17, 2025. This decline marks a notable downturn for the company, which has seen its stock price fall by 3.68% over the past two days, underperforming its sector by 1.05%.
The company's performance over the past year has been challenging, with a staggering 40.07% decrease in stock value compared to the Sensex's positive return of 3.73%. Mukka Proteins has consistently traded below its moving averages across various time frames, indicating a persistent downward trend.

Financial metrics reveal underlying issues, including a low Return on Capital Employed (ROCE) of 9.48% and a high Debt to EBITDA ratio of 4.36 times, suggesting difficulties in managing debt and profitability. Additionally, the company has reported negative results for six consecutive quarters, with net sales plummeting by 32.1% compared to previous averages.

As institutional investors have reduced their stake in Mukka Proteins by 0.65%, holding only 3.96% of the company, the stock's performance continues to reflect broader challenges within the organization.